相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of P450 1A1 and P450 1A2 in Bioactivation versus Detoxication of the Renal Carcinogen Aristolochic Acid I: Studies in Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) Mice
Volker M. Arlt et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
The Human Carcinogen Aristolochic Acid I Is Activated to Form DNA Adducts by Human NAD(P)H:quinone Oxidoreductase Without the Contribution of Acetyltransferases or Sulfotransferases
Marie Stiborova et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2011)
Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice
Volker M. Arlt et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model
Katerina Levova et al.
TOXICOLOGICAL SCIENCES (2011)
Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse
Thomas A. Rosenquist et al.
DRUG METABOLISM AND DISPOSITION (2010)
The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease
Imari Mimura et al.
NATURE REVIEWS NEPHROLOGY (2010)
Special Report: Policy A review of human carcinogens-Part A: pharmaceuticals
Yann Grosse et al.
LANCET ONCOLOGY (2009)
Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: A case series with 15-year follow-up
Anne Lemy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Generation of a 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-)_Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor
Zhanquan Shi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Aristolochic acid nephropathy: A worldwide problem
Frederic D. Debelle et al.
KIDNEY INTERNATIONAL (2008)
Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy
Marie Stiborova et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury
Xiang Xue et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Aristolochic acid mutagenesis:: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer
Volker M. Arlt et al.
CARCINOGENESIS (2007)
Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line
Nadine Dragin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
Arthur P. Grollman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The P-32-postlabeling assay for DNA adducts
David H. Phillips et al.
NATURE PROTOCOLS (2007)
Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry
Wan Chan et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen
M Stiborová et al.
CANCER LETTERS (2005)
Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2
C Cheung et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers
M Stiborová et al.
CANCER LETTERS (2005)
Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN)
SY Atanasova et al.
CLINICAL BIOCHEMISTRY (2005)
Interspecies metabolism of heterocyclic aromatic amines and the uncertainties in extrapolation of animal toxicity data for human risk assessment
RJ Turesky
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Human hepatic and renal microsomes, Cytochromes P450 1A1/2, NADPH:Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer
M Stiborová et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide
M Stiborová et al.
CANCER RESEARCH (2004)
Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid:: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase
M Stiborová et al.
CARCINOGENESIS (2003)
Aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?
VM Arlt et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids:: Evidence for reductive activation by cytochromes P450 1A1 and 1A2
M Stiborová et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
JL Nortier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
